Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Unknown 2Not yet recruiting 2Recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 2CNS 1

Conditions

Carcinoma, Non-Small-Cell Lung 11Brain Neoplasms 3Lung Neoplasms 2Adenocarcinoma of Lung 2Pleural Effusion, Malignant 1NSCLC 1

Interventions

aflutinib 2Pemetrexed 2lorlatinib 1anlotinib 1Platinum 1Orlistat 1Mastectomy, Segmental 1Diagnostic Imaging 1Carboplatin 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Not yet recruiting × Adenocarcinoma of Lung × aflutinib × Clear all
NCT07482605 2026-03-20

Furmonertinib Plus Radiotherapy for EGFR+ NSCLC With Pleural Effusion

Jiangmen Central Hospital

Phase 2 Not yet recruiting
63 enrolled
Thoracic

Adenocarcinoma of Lung, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Pleural Effusion, Malignant

NCT06483672 2024-07-03

LungBrain001

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Phase 2 Not yet recruiting
27 enrolled
CNSThoracic

Adenocarcinoma of Lung, Brain Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡